ENAH and systemic lupus erythematosus: As we also found no role for anti-ENA Ab and anti-C1q Ab in the risk of developing HC, this supports the assumption that in a significant proportion of SLE patients, alternate nonimmune complex-dependent complement pathway activation occurs quite frequently [36–39].